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Abstract
Objective—To identify predictors of perceived a) risk of harm associated with inhalant use and b)
intention to use inhalants among adolescent inhalant users.
Method—Participants were 279 lifetime inhalant users (Mage = 15.5, 84 % male) identified in a
statewide survey of 723 adolescents in Missouri Division of Youth Services’ residential care for
antisocial conduct. Youth completed interviews assessing inhalant and other drug use, psychiatric
symptoms, and antisocial traits/behavior.
Results—More than one-third (37%) of youth perceived experimental inhalant use as of slight or
no risk; one-in-eight (11.9 %) youth perceived regular inhalant use as of slight or no risk. Risk
perceptions of experimental and regular inhalant use were not associated with intentions to use. Youth
with friends/sibling inhalant who use inhalants were less likely to perceive risks associated with
experimental and regular inhalant use compared to youth without friends/sibling users. Adolescents
who were younger and those with more extensive substance abuse problems, prior problems with
inhalants, greater current psychiatric distress, friends/sibling who use inhalants were significantly
more likely to report intentions of future inhalant use than their counterparts.
Conclusions—Assessment of substance use among youth, particularly those in the criminal justice
system, should include an assessment of inhalants. Intervention efforts should include addressing
misperceptions of risk associated with inhalants and developing strategies for managing social
network influences.
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1. Introduction
Inhalant use is among the most pernicious and least studied forms of adolescent drug abuse
(Howard et al., 2008). Approximately 2 million U.S. adolescents use inhalants annually (Wu
et al., 2004). In 2006, 16.1 % of U.S. 8th graders reported prior inhalant use (Johnston et al.,
2007). Despite widespread use among adolescents, inhalant abuse has been called the
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“forgotten drug problem” due to the limited research historically accorded this class of agents
(Balster, 1997; Perron et al., 2007; Vaughn et al., 2007).
Several studies have examined predictors of initiation of inhalant use (e.g., Howard et al.,
1999), but few investigations have evaluated the extent to which adolescent inhalant users
consider inhalant use a potentially risky activity and factors associated with inhalant-related
risk perceptions. Further, the role that risk perceptions play in adolescent inhalant users’
expectancies for future inhalant use is presently unclear, although limited findings suggest that
perceptions of harm are inversely related to inhalant use (e.g., Beauvais, 1992). Recent research
indicates that self-reported intentions to use inhalants are significantly related to future inhalant
use, consistent with the theory of reasoned action (Crano et al., In press). Thus, studies
identifying correlates of inhalant-related risk perceptions and intentions to use inhalants may
provide valuable information to guide prevention and treatment programming in this
increasingly important area.
Juvenile offenders are an important population in which to study inhalant use. Inhalant use and
its consequences are prevalent in many subpopulations of youth exhibiting delinquent
behaviors and can be readily assessed when youth are in residential care and free of inhalant
use and acute substance-related functional impairments (Howard and Jenson, 1999). In a
recently completed survey of Missouri youth court-ordered into residential treatment for
antisocial behavior (which forms the basis for this report), 38.6 % of 723 youth were identified
as lifetime inhalant users (Howard et al., 2008). Besides being problematic in the United States,
inhalant use is prevalent among children and adolescents in many other nations. Medina-Mora
and Real (2008) reviewed recently reported epidemiological studies of inhalant use among
citizens of Brazil, Mexico, Paraguay, Chile, Columbia, Nicaragua, Spain, Canada, New
Zealand, and Australia, concluding that inhalant use is “widespread among children and
adolescents and is increasing among females in the developing and developed world [and
associated with] increased risk of injection drug use, HIV, suicidality, and psychiatric disorders
among inhalant users” (p. 247). High rates of inhalant use and inhalant-related problems have
also recently been identified among Russian street youth (Kissin et al., 2007), Japanese high
school students (Shimane and Wada, 2007), and youth in eastern European countries. Greater
knowledge as to the correlates of inhalant-related risk perceptions and intentions/expectancies
to use inhalants could do much to improve the treatment of adolescent inhalant users, especially
those treated in juvenile justice and other rehabilitative settings.
We hypothesized that youth with comparatively high levels of antisocial behavior and attitudes,
substance abuse problems, self-reported prior problems with inhalants, friends or sibling who
use inhalants, and otherwise high-risk sociodemographic profiles would report lower levels of
perceived risk of harm in association with experimental and regular inhalant use. We further
hypothesized that these factors, in conjunction with lower levels of perceived risk of harm in




Findings of the present study are based on a survey conducted in 2003 of the population of
current residents of the Missouri Division of Youth Services’ (MDYS) residential rehabilitation
system. A detailed description of the study sample and survey is available in Howard et al.
(2008). The MDYS is the legal guardian of all residents who are committed to its care by the
state’s 45 juvenile courts. The 723 adolescents who completed the interview constituted 97.7
% of MDYS residents at the time interviewing was conducted and 55.0 % of youth committed
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to MDYS care in the prior year. The informed consent and study protocols were approved by
the Missouri DYS and Washington University IRBs and Office of Human Research Protection.
2.2 Measures
All participants completed the Volatile Solvent Screening Inventory (VSSI), an interview
assessing demographic characteristics, medical history, lifetime/annual use of 65 inhalants,
other drug use and substance-related problems, current psychiatric symptoms, thoughts of
suicide/actual suicide attempts, trauma history, antisocial traits and criminal activity. All youth
reporting any lifetime use of an inhalant in an effort to get high also completed the
Comprehensive Solvent Assessment Interview (CSAI), a schedule evaluating reasons for
starting and stopping inhalant use, typical modes, locations, contexts and subjective effects of
inhalant use, adverse consequences/high-risk behaviors occurring in association with acute
inhalant intoxication, perceived risks of inhalant use, estimated likelihood that inhalants will
be used in the future, sibling and friend’s use of inhalants, and DSM-IV Inhalant Abuse and
Dependence criteria. This study included all youth reporting lifetime use of inhalants to get
high (N = 279).
2.2.1 Perceived risk of harm of inhalant use—Youth were asked how much they think
people risk harming themselves physically and in other ways if they try inhalants once or
twice (experimental use), and if they use inhalants regularly (regular use). Response options
for the two perceived risk questions were: 0 = No risk, 1 = Slight risk, 2 = Medium risk, 3 =
Great risk.
2.2.2 Intentions of future inhalant use—Youth who had used one or more volatile solvent
inhalants (i.e., all participants in this study) were asked: “During the next year (after you are
released from custody) how likely are you to use inhalants?” Responses were recorded on a
five-point Likert-type scale (0 = No chance, 1 = Little chance, 2 = An even chance, 3 = A good
chance, 4 = I’m sure to).
2.2.3 Inhalant and other substance related measures—Youth were asked whether
they had ever “had a problem” with inhalants before they entered custody (0 = No vs. 1 =
Yes). .Inhalant use within a youth’s social network reflected whether any of the respondents’
friends (yes/no) or siblings (yes/no) currently used inhalants. Lifetime substance-related
problems were assessed with the 8-item Alcohol/Drug Use Scale of the Massachusetts
Adolescents Screening Instrument—2nd Version (MAYSI-2) (Grisso and Barnum, 2000).
Scores could range from 0–8, with higher values representing a greater number of problems.
2.2.7. Psychiatric variables—Youth completed the Brief Symptom Inventory (BSI),
consisting of 53 items assessing the extent to which they were “bothered or disturbed” (0 = not
at all; 4 = extremely) by a variety of thoughts or feelings “over the last 7 days including
today” (Derogatis, 1993). A global severity index (GSI) score was computed by summing all
items. Antisocial attitudes were assessed using the total score of the Psychopathic Personality
Inventory (PPI; Lilienfeld and Andrews, 1996) and the Self-Rerpot of Delinquency (Elliott et
al., 1989).
2.2.8. Demographic and psychosocial variables—Gender, age, self-reported racial
status, family receipt of public assistance, and geographical area of family residence (i.e.,
urban, suburban, small town, rural) were recorded for each youth. Youth were also asked to
report the duration (months) of their current residential treatment episode.
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Descriptive statistics were used to summarize results. Given the skewed distributions of the
dependent measures, non-parametric correlations were computed (i.e., Spearman rank-order
correlation). Ordinal logistic regression used to test multivariate associations and study
hypotheses. Adjusted odds ratios (OR) and 95% confidence intervals were computed to
indicate statistical significance and effect sizes.
3. Results
3.1 Characteristics of inhalant user sample
Approximately 82% (n = 230) of the sample reported a “White” racial identification and 18%
(n = 49) was non-White. Eighty-four percent of youth were male, and ages ranged from 11 to
20 (Mean = 15.5, SD = 1.2). Thirty-nine percent (n = 109) of youth reported that their family
currently received public assistance. Prior to being ordered into residential care, 59% of
respondents (n = 166) lived in small town/rural areas and 41% (n = 113) lived in urban/suburban
areas. The current episode of incarceration for youth ranged from 0 to 60 months, (Mean = 7.5,
SD = 8.5). Approximately 37% (n = 93) of youth reported having friends or siblings who used
inhalants, and 38% (n = 106) reported having a problem with inhalants prior to incarceration.
Table 1 provides a univariate summary of the other study measures.
3.2. Summary of Perceived Harm and Intentions of Future Inhalant Use
Approximately 38% of youth indicated that experimental use of inhalants was associated with
a great risk of harm, 24 % perceived a medium risk, 27% perceived a slight risk, and 10%
perceived no risk (see Table 1). A higher percentage of youth perceived regular inhalant use
to be associated with great risk of harm (71%). Approximately 18% believed regular inhalant
use was associated with a medium risk, and only small percentages believed regular inhalant
use was associated with slight (7.2%) or no risk (4.7%). A Spearman rank correlation showed
the measures of perceived harm to have a moderately strong correlation (ρ = .62, p < .0001).
The majority of adolescent inhalant reported no intention of future inhalant use (74%).
Approximately 16% perceived a small likelihood, and 7% perceived an even chance. A small
percentage reported an elevated likelihood of future use – that is, 3% perceived a good chance,
and 1% was “sure to use.” A Spearman rank correlation showed intention of future use to have
a weak negative association with perceived risk of harm with experimental inhalant use (ρ =
−.12, p = .05), and a non-significant association with perceived risk of harm with regular
inhalant use (ρ = −.03, p = .60).
3.3 Multivariate Associations
Multivariate ordinal logistic regression was used to identify factors associated with perceived
risk of harm with using inhalants and intentions of future inhalant use among youth with a
lifetime inhalant use. Table 1 summarizes odds ratios for the three models that were specified.
Contrary to the study hypothesis, only one variable was associated with perceived risk of harm.
Specifically, youth who reported having friends or siblings who used inhalants were
significantly more likely to report a lower risk of harm compared to youth without friends or
siblings who used inhalants. This variable was significant for both risk of harm with
experimental use of inhalants (OR = .55, 95% CI = .34 – .89) and regular use of inhalants (OR
= .47, 95% CI = .47, 95% CI = .26 – .82).
Youth with friends or siblings who used inhalants were over three times more likely to report
a higher likelihood of future inhalant use compared to youth without these network influences
(OR = 3.33, 95% CI = 1.77 – 6.29). Being younger, reporting greater current psychiatric
distress, evidencing more extensive substance abuse problem histories including prior
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problems with inhalants also increased likelihood of future inhalant use. Contrary to our
hypothesis, there was no evidence that perceptions of harm were significantly associated with
perceived likelihood of future inhalant use.
4. Discussion
Nearly 90% of adolescent inhalant users perceived regular inhalant use as a moderately-to-
highly risky activity. Yet, more than one-quarter of youth reported some likelihood of future
inhalant use. This figure may be significantly underestimated if youth perceived some incentive
to minimize or misrepresent their future inhalant use intentions. Given that inhalant use is
strongly influenced by proximal social contexts (Vaughn et al., 2007) and peer influences
(Perron et al., 2008), it is also possible that youth perceived little likelihood of future inhalant
use within the study setting, but that contextual factors could operate to increase risk for
inhalant use in the future. This is particularly relevant given that perceptions of harm of inhalant
use were uncorrelated with intentions to use, but social networks exhibited a stable association.
Inhalant prevention and treatment efforts should focus on important and easily assessed
correlates of future intentions to use inhalants including self-reports of a prior problem with
inhalants and social networks including family and friends who use inhalants. Adolescent
inhalant users who are younger , in greater psychiatric distress, and with more extensive
substance use problems were also easily identified groups at risk for future inhalant use in this
juvenile justice population.(Howard et al., 2008, Wu and Howard, in press). In light of the
substantial prevalence and seriously adverse consequences of inhalant use within this
population (Sakai et al., 2004; Storr et al., 2007; Williams et al., 2007), it is critical that juvenile
justice programs implement effective methods for identifying and intervening with youth who
are at risk for commencing, maintaining, and intensifying inhalant use following discharge
from treatment.
Strengths of this investigation included the large sample of inhalant users, use of face-to-face
structured interviews, high study participation rate, examination of an important and
understudied clinical population at high risk for inhalant-related problems, and focus on an
under researched issue. Limitations include the self-report nature of the assessments and
possibly limited generalizability of study findings given that the sample was comprised of
youth who are incarcerated.
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Table 1
Ordinal Logisitic Regression Testing the Association of Perceived Risk of Harm and Intentions of Future Inhalant Use
with Demographic, Psychosocial, and Clinical Measures









Mean (SD) AOR (95% CI) AOR (95% CI) AOR (95% CI)
Age 11 – 20 15.5 (1.2) .96 (.78 – 1.19) 1.00 (.78 – 1.29) .74 (.56 – .99)
Gender
  Female 16%, n = 44 Ref Ref Ref
  Male 84%, n = 235 1.23 (.68 – 2.20) 1.65 (.77 – 3.56) .82 (.37 – 1.81)
Ethnicity
  Non-White 18%, n = 49 Ref Ref Ref
  White 82%, n = 230 .81 (.47 – 1.40) .68 (.34 – 1.35) 1.00 (.48 – 2.07)
Public Assistance
  No 61%, n = 170 Ref Ref Ref
  Yes 39%, n = 109 1.06 (.67 – 1.66) 1.24 (.71 – 2.17) .64 (.34 – 1.21)
Urbanicity
  Rural/Small town 59%, n = 166 Ref Ref Ref
  Urban/Suburban 41%, n = 113 1.08 (.68 – 1.72) 1.23 (.71 – 2.16) .69 (.37 – 1.29)
Months of incarceration 7.5 (8.5) 1.09 (.88 – 1.34) 1.11 (.84 – 1.46) .89 (.65 – 1.22)
Perceived problem with
inhalants
  No 62%, n = 173 Ref Ref Ref
  Yes 38%, n = 106 1.13 (.71 – 1.81) 1.25 (.71 – 2.20) 2.39 (1.27 – 4.49)
MAYSI-2 – substance use
problems index
5.2 (2.1) 1.13 (.69 – 1.85) 1.31 (.73 – 2.34) 2.13 (1.01 – 4.50)
Perceived harm of inhalants
– single use
  No risk 10%, n = 29 † † Ref
  Slight risk 27%, n = 76 .57 (.15 – 2.29)
  Medium risk 24%, n = 67 1.71 (.38 – 7.66)
  Great risk 38%, n = 107 .23 (.05 – 1.07)
Perceived harm of inhalants
– regular use
  No risk 4.7%, n = 13 † † Ref
  Slight risk 7.2%, n = 20 .50 (.07 – 3.85)
  Medium risk 18.0%, n = 49 .61 (.09 – 3.90)
  Great risk 71.0%, n = 197 .99 (.15 – 6.63)
Friends or siblings use
inhalants
  No 63%, n = 186 Ref Ref Ref
  Yes 37%, n = 93 .55 (.34 – .89) .47 (.26 – .82) 3.33 (1.77 – 6.29)
Global Severity Index‡ 53.82 (37.16) 1.40 (.96 – 2.04) 1.35 (.87 – 2.10) 2.30 (1.24 – 4.26)
PPI total‡ 141.5 (15.06) .91 (.68–1.20) .99 (.71 – 1.38) 1.13 (.75 – 1.71)
Total delinquency 31.26 (20.76) 1.22 (.84–1.78) .92 (.59 – 1.43) .87 (.53 – 1.42)
†
Note: Excluded from the model.
‡
Univariate findings are reported in raw scale values; values were log-transformed in multivariate analysis due to high skewness. AOR = Adjusted odds
ratio. CI = Confidence Interval. Ref = Reference group. Values in bold are statistically significant based on a 95% CI.
a
Model fit: AIC = 434.78, Residual Deviance = 390.78
b
AIC = 737.20, Residual Deviance = 707.20
c
AIC = 507.63, Residual Deviance = 477.63.
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